MADALYN AXFORD: Open Payments
NPI 1245000694 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,737 in 69 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,737
Food & beverage: $1,737
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $321 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $299 |
| ABBVIE INC. | 13 | $241 |
| QOL Medical, LLC | 2 | $130 |
| Janssen Biotech, Inc. | 6 | $129 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Intercept Pharmaceuticals, Inc. | 3 | $85 |
| Aimmune Therapeutics, Inc. | 3 | $65 |
| Lilly USA, LLC | 3 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
Products named: DUPIXENT, TREMFYA, ENTYVIO, Sucraid, RINVOQ, EOHILIA, LINZESS, OCALIVA.
Industry payments across MI — which companies pay providers there.
